A drug with the SMILES CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc2sc3c(c2c1=O)CCN(C)C3 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 19.979\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc2sc3c(c2c1=O)CCN(C)C3
CCn1c(SCC(=O)Nc2ccc(Br)cc2)nc2sc3c(c2c1=O)CCN(C)C3
N-(4-bromophenyl)-2-[(4-ethyl-11-methyl-3-oxo-8-thia-4,6,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),5-trien-5-yl)sulfanyl]acetamide